#Lila Bio

Coverage of Lila Bio focuses on the startup and its role within the venture and innovation landscape, with attention to how emerging biotech companies develop, scale, and attract investor interest. This topic archive brings together reporting on the company’s business trajectory, funding context, and broader relevance to AI-enabled or science-driven entrepreneurship.

Lila Bio wins $3.65M NIH grant for pulmonary hypertension

Lila Bio said it received a $3.65 million NIH SBIR Fast-Track grant to develop AI-designed protein drugs for pulmonary hypertension.

Nov 12, 2026 · 3 min